Literature DB >> 22130228

Foreword. Target therapy for cancer: anti-cancer drugs targeting growth-factor signaling molecules.

Fumiaki Ito1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22130228     DOI: 10.1248/bpb.34.1773

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


× No keyword cloud information.
  4 in total

1.  Platelet VEGF and serum TGF-β1 levels predict chemotherapy response in non-small cell lung cancer patients.

Authors:  Bao-Hong Fu; Zhan-Zhao Fu; Wei Meng; Tao Gu; Xiao-Dong Sun; Zhi Zhang
Journal:  Tumour Biol       Date:  2015-03-29

2.  Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors.

Authors:  Li Tan; Jun Wang; Junko Tanizaki; Zhifeng Huang; Amir R Aref; Maria Rusan; Su-Jie Zhu; Yiyun Zhang; Dalia Ercan; Rachel G Liao; Marzia Capelletti; Wenjun Zhou; Wooyoung Hur; NamDoo Kim; Taebo Sim; Suzanne Gaudet; David A Barbie; Jing-Ruey Joanna Yeh; Cai-Hong Yun; Peter S Hammerman; Moosa Mohammadi; Pasi A Jänne; Nathanael S Gray
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-27       Impact factor: 11.205

3.  Predictive and prognostic molecular markers for cholangiocarcinoma in Han Chinese population.

Authors:  Lingqin Meng; Zhong Tian; Yong Wang; Yuan Liu; Jingang Liu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 4.  Durable efficacy of anlotinib in a patient with advanced thymic squamous cell carcinoma after multiline chemotherapy and apatinib: A case report and literature review.

Authors:  Ran Zuo; Cuicui Zhang; Li Lin; Zhaoting Meng; Yajie Wang; Yudong Su; Mihray Abudurazik; Ye Du; Peng Chen
Journal:  Thorac Cancer       Date:  2020-09-30       Impact factor: 3.500

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.